NEW DRUGS - LIPID LOWERING DRUGS

被引：88

作者：

OCONNOR, P

FEELY, J

SHEPHERD, J

机构：

[1] TRINITY COLL DUBLIN, ST JAMES HOSP, SCH MED, LIPID CLIN, DUBLIN 8, IRELAND

[2] GLASGOW ROYAL INFIRM, DEPT PATHOL BIOCHEM, GLASGOW G4 0SF, SCOTLAND

来源：

BMJ-BRITISH MEDICAL JOURNAL | 1990年 / 300卷 / 6725期

关键词：

D O I：

10.1136/bmj.300.6725.667

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：667 / 672

页数：6

共 44 条

[1]

BAKER SG, 1982, S AFR MED J, V62, P7

[2]

BALL MJ, 1986, Q J MED, V60, P733

[3] COMPARATIVE TOXICITY AND SAFETY PROFILE OF FENOFIBRATE AND OTHER FIBRIC ACID-DERIVATIVES [J].

BLANE, GF .

AMERICAN JOURNAL OF MEDICINE, 1987, 83 (5B) :26-36

[4] EFFECTS OF THERAPY WITH CHOLESTYRAMINE ON PROGRESSION OF CORONARY ARTERIOSCLEROSIS - RESULTS OF THE NHLBI TYPE-II CORONARY INTERVENTION STUDY [J].

BRENSIKE, JF ;

LEVY, RI ;

KELSEY, SF ;

PASSAMANI, ER ;

RICHARDSON, JM ;

LOH, IK ;

STONE, NJ ;

ALDRICH, RF ;

BATTAGLINI, JW ;

MORIARTY, DJ ;

FISHER, MR ;

FRIEDMAN, L ;

FRIEDEWALD, W ;

DETRE, KM ;

EPSTEIN, SE .

CIRCULATION, 1984, 69 (02) :313-324

[5] HOW LDL RECEPTORS INFLUENCE CHOLESTEROL AND ATHEROSCLEROSIS [J].

BROWN, MS ;

GOLDSTEIN, JL .

SCIENTIFIC AMERICAN, 1984, 251 (05) :58-&

[6] EFFECTS OF FENOFIBRATE ON PLASMA-LIPIDS - DOUBLE-BLIND, MULTICENTER STUDY IN PATIENTS WITH TYPE-IIA OR TYPE-IIB HYPERLIPIDEMIA [J].

BROWN, WV ;

DUJOVNE, CA ;

FARQUHAR, JW ;

FELDMAN, EB ;

GRUNDY, SM ;

KNOPP, RH ;

LASSER, NL ;

MELLIES, MJ ;

PALMER, RH ;

SAMUEL, P ;

SCHONFELD, G ;

SUPERKO, HR .

ARTERIOSCLEROSIS, 1986, 6 (06) :670-678

[7] 15 YEAR MORTALITY IN CORONARY DRUG PROJECT PATIENTS - LONG-TERM BENEFIT WITH NIACIN [J].

CANNER, PL ;

BERGE, KG ;

WENGER, NK ;

STAMLER, J ;

FRIEDMAN, L ;

PRINEAS, RJ ;

FRIEDEWALD, W .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) :1245-1255

[8] PHARMACOLOGY OF FENOFIBRATE [J].

CHAPMAN, MJ .

AMERICAN JOURNAL OF MEDICINE, 1987, 83 (5B) :21-25

[9]

CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36

[10] PLASMA-LIPID LOWERING ACTIVITY OF ACIPIMOX IN PATIENTS WITH TYPE-II AND TYPE-IV HYPERLIPOPROTEINEMIA - RESULTS OF A MULTICENTER TRIAL [J].

CREPALDI, G ;

AVOGARO, P ;

DESCOVICH, GC ;

DIPERRI, T ;

POSTIGLIONE, A ;

SIRTORI, CR ;

STRANO, A ;

VENTURA, S ;

MUSATTI, L .

ATHEROSCLEROSIS, 1988, 70 (1-2) :115-121

← 1 2 3 4 5 →